Relmada Therapeutics Inc (RLMD) Unusual Options Activity Today

Checking RLMD unusual options activity helps you spot when traders are making outsized bets on Relmada Therapeutics Inc before the broader market catches on. Relmada Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor RLMD unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching RLMD unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking RLMD unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and RLMD unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Catalysts rarely arrive without a footprint, and RLMD unusual options activity is often where that footprint shows up first. Our scanner tracks Relmada Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at RLMD unusual options volume on the call side or chasing put sweeps, Relmada Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.